✨ Medicines Notices




1056

NEW ZEALAND GAZETTE

No. 36

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Colistin sulphomethate sodium 0.24 mg (3,000,000 IU), erythromycin glucoheptonate 0.65 g equivalent to 0.5 g erythromycin base Bone cement, powder component Pfizer GmbH, Karlsruhe, Germany Antibiotic Simplex
Deflazacort 6 mg, 30 mg Tablets Gruppo Lepetit S p A., Anagni (Frosinone), Italy Calcort
Cajuput oil 20 mg, camphor 20 mg, eucalyptus oil 20 mg, melaleuca alternifolia oil 20 mg, menthol 20 mg, methyl salicylate 120 mg, peppermint oil 20 mg in 30 g, 60 g and 120 g Ointment Ramprie Laboratories, Division of Narwhal Pty Limited, Welshpool, Western Australia, Australia Mt Romance Emu Oil Deep Rub
Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium Tablet, chewable Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada Mylanta Rolltabs (Fruit Flavour)
Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium Tablet, chewable Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada Mylanta Rolltabs (Peppermint Flavour)
Calcium carbonate 317 mg equivalent to 127 mg elemental calcium, magnesium hydroxide 64 mg equivalent to 26 mg elemental magnesium Tablet, chewable Adams Brands Manufacturing, Division Warner Lambert Canada Inc., Scarborough, Ontario, Canada Mylanta Rolltabs (Spearmint Flavour)
Tamsulosin hydrochloride 0.4 mg Capsule Yamanouchi Pharmaceutical Co Limited, Nishine-cho, Iwate-gun, Iwate-ken, Japan Omnic 0.4
Ranitidine bismuth citrate 400 mg Tablet Glaxo Operations UK Limited, Ware, Hertfordshire, United Kingdom Pylorid
Guaiphenesin 20 mg/mL in 100 mL, 200 mL Syrup Wyeth Australia Pty Limited, Smithfield, New South Wales, Australia Robitussin EX

Dated this 12th day of April 1996.

G. R. BOYD, Acting Assistant General Manager, Health Regulation & Protection, pursuant to delegation given by the Minister of Health on 18 January 1996.

g02520

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines set out in the Schedule hereto:

Schedule

Name and Strength Form Name and Address of Manufacturer Proprietary Name (if any)
Captopril 37.5 mg Tablet Bristol-Myers Squibb Pharmaceuticals Limited, Moreton, Wirral, Merseyside, England and Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia Capoten D
Carboxymethylcellulose 5 mg/mL in 0.4 mL Drops, eye Allergan Optical, Allergan Inc., Waco, Texas, United States of America Cellufresh
Triptorelin acetate 4 mg equivalent to 3.75 mg triptorelin Solution for injection, prefilled syringe Ferring AB., Malmo, Sweden and Ferring Arzneimittel GmbH., Keil, Germany Decapeptyl-CR
Isosorbide mononitrate 120 mg Tablet, modified release Astra Pharmaceutical Production AB., Sodertalje, Sweden Imdur Durules
Omeprazole 20 mg Capsule Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec
Omeprazole sodium 42.6 mg equivalent of 40 mg omeprazole in 10 mL Powder for injection (ampoule) and diluent (ampoule) Astra Pharmaceutical Production AB., Sodertalje, Sweden Losec IV


Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 36


NZLII PDF NZ Gazette 1996, No 36





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of Medicines

πŸ₯ Health & Social Welfare
12 April 1996
Medicines, Distribution, Consent, Pharmaceuticals, Health Regulation
  • G. R. Boyd, Acting Assistant General Manager, Health Regulation & Protection

πŸ₯ Consent to the Distribution of Changed Medicines

πŸ₯ Health & Social Welfare
Medicines, Distribution, Consent, Changed Medicines, Pharmaceuticals